HIV-1 Nef Breaches Placental Barrier in Rat Model

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Singh, Poonam ^a   Agnihotri, Saurabh Kumar ^a   Tewari, Mahesh Chandra ^a   Kumar, Sadan ^a   Sachdev, Monika ^a   Tripathi, Raj Kamal ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EVANS BLUE; NEF PROTEIN; RECOMBINANT PROTEIN;

AMNION FLUID; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BLOOD BRAIN BARRIER; BLOOD PLACENTA BARRIER; BRAIN TISSUE; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; FETUS (ANATOMY); FETUS GROWTH; IMMUNOFLUORESCENCE TEST; MALE; MOLECULAR DYNAMICS; MOTHER FETUS RELATIONSHIP; NONHUMAN; PLACENTA; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; UTERUS;

AMNIOTIC FLUID; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PLACENTA; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; UTERUS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; RATTUS;

EID: 84871145677     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051518     Document Type: Article

References (41)

1. Mishra MK, Dutta K, Saheb SK, Basu A, (2009) Understanding the molecular mechanism of blood-brain barrier damage in an experimental model of Japanese encephalitis: Correlation with minocycline administration as a therapeutic agent. Neuro Chem Int 55: 717-723.
2. Greenwood J, (1991) Mechanism of blood brain barrier Breakdown. Neurobiology 33: 95-100.
3. Dallasta LM, Pisarov LA, Esplen JE, Werley JV, Moses AV, et al. (1999) Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol 155: 1915-1927.
4. Diamond MS, Klein RS, (2004) West Nile virus: crossing the blood-brain barrier. Nat Med 10: 1294-1295.
5. Kwiek JJ, Mwapasa V, Milner DA, Alker AP, Miller WC, et al. (2006) Maternal-fetal microtransfusions and HIV-1 mother-to-child transmission in Malawi. PLoS Med 3(1): e10.
6. Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, et al. (1996) Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS ClinicalTrials Group Protocol 076 Study Group. N Engl J Med 335: 1621-1629.
7. Mofenson LM, Lambert JS, Tiehm ER, Bethel J, Meyer WA, et al. (1999) Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine.Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med 341: 385-393.
8. Chandwani S, Greco MA, Mittal K, Antoine C, Krasinski K, et al. (1991) Pathology of human immunodeficiency virus expression in placenta of seropositive women. J Infect Dis 163 5: 1134-1138.
9. Lewis SH, Reynolds-Kohler C, Fox HE, Nelson JA, (1990) HIV-1 in trophoblastic and villous Hofbauer cells, and hematologic precursors in eight week fetuses. Lancet 335: 565.
10. Bagasra O, Bobroski L, Saikumari P, Pestaner JP, Seshamma T, et al. (1995) Presence of HIV-1 in placentas of HIV-1 seropositive mothers by in situ PCR. Natl Conf Hum Retroviruses Relat Infect 2: 136.
11. McGann KA, Collman R, Kolson DL, Gonzalez-Scarano F, Coukos G, et al. (1994) Human immunodeficiency virus type 1 causes productive infection of macrophages in primary placental cell cultures. J Infect Dis 169: 746-753.
12. Al-husaini AM, (2009) Role of placenta in the vertical transmission of human immunodeficiency virus. J Perin 29: 331-336.
13. Derrien M, Faye A, Dolcini G, Chaouat G, Derrien M, et al. (2005) Placental Cytokine-Chemokine Balance on Regulation of Cell-Cell Contact- Induced Human Immunodeficiency Virus Type 1 Translocation across a Trophoblastic Barrier In Vitro. J Virol 79: 12304-12310.
14. Mulder-Kampinga GA, Simonon A, Kuiken CL, Dekker J, Scherpbier HJ, et al. (1995) Similarity in env and gag genes between genomic RNAs of human immunodeficiency virus type 1 (HIV-1) from mother and infant is unrelated to time of HIV-1 RNA positivity in the child. J Virol 69: 2285-2296.
15. Mullard A, (2008) Infectious Disease: Finding the keys to the placental barrier. Nat Rev Microbiol 6: 798-798.
16. Venkat RKY, Ahmad N, (2001) Low conservation of functional domains of HIV type 1 vif and vpr genes in infected mothers correlates with lack of vertical transmission. AIDS Res Hum Retroviruses 17: 911-923.
17. Venkat RKY, Husain M, Horodner A, Ahmad N, (2001) Molecular characterization of HIV type 1. vpu genes from mothers and infants after perinatal transmission. AIDS Res Hum Retroviruses 17: 1089-1098.
18. Husain M, Hahn T, Yedavalli VR, Ahmad N, (2001) Characterization of HIV type 1 tat sequences associated with perinatal transmission. AIDS Res Hum Retroviruses 17: 765-773.
19. Hahn T, Ramakrishnan R, Ahmad N, (2003) Evaluation of genetic diversity of human immunodeficiency virus type 1 NEF gene associated with vertical transmission. J Biomed Sci 10: 436-450.
20. Acheampong EA, Cassandra R, Muhammad M, Alagarsamy S, Mohammad R, et al. (2009) Combined effects of hyperglycemic conditions and HIV-1 Nef: a potential model for induced HIV neuropathogenesis. J Virol 6 10: 183.
21. Cavarelli M, Scarlatti G, (2010) HIV-1 co-receptor usage:influence on mother-to-child transmission and pediatric infection. J Transl Med 9: S1-S10.
22. Patterson BK, Behbahani H, Kabat WJ, Sullivan Y, O'Gorman MR, et al. (2001) Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women. J Clin Invest 107: 287-94.
23. Mordelet E, Kissa K, Cressant A, Gray F, Ozden S, et al. (2004) Histopathological and cognitive defects induced by Nef in the brain. The Faseb Journal 18: 1851-1861.
24. Mathur A, Khanna N, Chaturvedi UC, (1992) Breakdown of blood-brain barrier by virus-induced cytokine during Japanese encephalitis virus infection. Int J Exp Pathol 73: 603-611.
25. Chaturvedi UC, Dhawan R, Khanna M, Mathur A, (1991) Break down of blood-brain barrier during dengue virus infection of mice. J Gen Virol 72: 859-866.
26. Sporer B, Koedel U, Paul R, Kohleisen B, Erfle V, et al. (2000) Human Immunodeficiency virus type-1 Nef protein induces blood-brain barrier disruption in the rat: role of matrix metalloproteinase-9. Neuroimmunol 102: 125-30.
27. Foster JL, Garcia JV (2008) HIV-1 Nef: at the crossroads. Retrovirol: 5-84.
28. D'costa GF, Khadke K, Vishwasrao PY, (2007) Pathology of placenta in HIV infection. Indian J Pathol Microbiol 50: 515-519.
29. Kwon BS, Tan KB, Ni J, Oh KO, Lee ZH, et al. (1997) A newly identified member of the tumor necrosis factor receptor super family with a wide tissue distribution and involvement in lymphocyte activation. J Biol Chem 272: 14272-14276.
30. Nazir A, Sammi SR, Singh P, Tripathi RK, (2010) Trans-Cellular Introduction of HIV-1 Protein Nef Induces Pathogenic Response in Caenorhabditis elegans. Plos One 5: e15312.
31. Hanna Z, Priceputu E, Hu C, Vincent P, Jolicoeur P, (2006) HIV-1 Nef mutations abrogating down regulation of CD4 affects other Nef functions and show reduced pathogenecity in transgenic mice. J Virol 346: 40-52.
32. Arold ST, Baur AS, (2001) Dynamic Nef and Nef dynamics: how structure could explain the complex activities of this small HIV protein. Trends Biochem Sci 26: 6.
33. Greenway AL, HollowayG, Mcphee DA, Ellis P, Cornall A, et al. (2003) HIV-1 Nef control of cell signalling molecules: multiple strategies to promote virus replication. J Bio Sci 28: 3.
34. Patterson B, Behbahani H, Kabat WJ, Sullivan Y, Maurice RG, et al. (2001) Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women. J Clin Invest 107: 287-294.
35. Pornprasert S, Faye A, Mary JY, Dolcini G, Leechanachai P, (2006) Down Modulation of TNF-α mRNA Placental Expression by AZT Used for the Prevention of HIV-1 Mother-to-Child Transmission. Placenta 27: 989-995.
36. Frenkel LM, Cowles MK, Shapiro DE, Melvin AJ, Watts DH, et al. (1997) Analysis of the maternal component of the AIDS clinical trail group 076 zidovudine regimen in the prevention of mother-to-infant transmission of human immunodeficiency virus type 1. J Infet Dis 175: 971-974.
37. Bai H, Zhang L, Ma L, Dou XG, Feng GH, et al. (2007) Relationship of hepatitis B virus infection of placental barrier and hepatitis B virus intra uterine mechanism. World J Gastroenterol 13: 3625-3630.
38. Wu Y, Marsh JW, (2001) Selective Transcription and Modulation of Resting T Cell Activity by Preintegrated HIV DNA. Science 293: 1503-1506.
39. Cao Y, Krogstad P, Korber BT, Koup RA, Muldoon M, et al. (1997) Maternal HIV-1 viral load and vertical transmission of infection: The Ariel Project for the prevention of HIV transmission from mother to infant. Nat Med 3: 549-552.
40. Hanna Z, Kay DG, Rebai N, Guimond A, Jothy S, et al. (1998) Nef Harbors a Major Determinant of Pathogenicity for an AIDS-like Disease Induced by HIV-1 in Transgenic Mice. Cell 95: 163-175.
41. Singh P, Yadav GP, Gupta S, Ramachandran R, Tripathi AK, et al. (2011) A Novel Dimer-Tetramer Transition Captured by the Crystal Structure of the HIV-1 Nef. J Plos ONE 6: e26629.